 Telegraph.co.uk | Cancer patients facing race against clock for drugs in fund 'betrayal' Telegraph.co.uk Drugs which are not on the central list include rituximab for blood cancers, one of the most commonly requested treatments under the previous fund, as well as alemtuzumab for leukaemia, erlotinib for lung cancer, trabectedin for ovarian cancer, and ... The great cancer betrayal: Number of treatments on approved list for patients ... |
